Thursday, May 18, 2023 11:10:10 AM
https://www.barchart.com/stocks/quotes/envb/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100
https://www.barchart.com/stocks/quotes/envb/opinion
Open gap at $1.52
Recent ENVB News
- Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds • Business Wire • 12/02/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/27/2024 09:36:12 PM
- Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior • Business Wire • 11/25/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2024 09:45:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:10:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:05:28 PM
- Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results • Business Wire • 11/14/2024 09:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/13/2024 04:18:03 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/12/2024 06:43:47 PM
- Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002 • Business Wire • 11/12/2024 02:00:00 PM
- Enveric Biosciences Announces Broad Range of Patent Issuances • Business Wire • 11/04/2024 03:36:00 PM
- Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003 • Business Wire • 10/15/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:23:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:21:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:18:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:16:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:14:11 PM
FEATURED Actelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market Eyes Trillions and Infrastructure Cyber Security Gains Importance - $ASNS • Dec 11, 2024 8:30 AM
Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN • SLXN • Dec 11, 2024 9:22 AM
Actelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market.. • ASNS • Dec 11, 2024 8:30 AM
Consumer Automotive Finance, Inc. Cancels an Additional 50 Million Common Shares with Shareholder Commitment to Retire 250 Million More Common Shares • CAFI • Dec 10, 2024 1:30 PM
Strategic Investments Spark Renewed Interest in Multi-Club Ownership Models • MSGS • Dec 10, 2024 1:11 PM
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance • CAFI • Dec 9, 2024 9:30 AM